Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Serotonergic psychedelics, including psilocybin, show early promise for treating diverse neuropsychiatric disorders, but their therapeutic mechanisms are unclear. In a nonrandomized, single-arm pilot trial1 that enrolled people with Parkinson disease (PD) and mood dysfunction, psilocybin therapy was associated with improvements in depression as well as motor function.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.